API reference
Terconazole
- CAS number
- 67915-31-5
- Molecular formula
- C26H31Cl2N5O3
- Molecular weight
- 532.5 g/mol
About this molecule
Terconazole is an anti-fungal drug that is mainly used to treat vaginal yeast infections (or vaginal candidiasis). It is classified as a triazole ketal derivative. Terconazole was initially approved by the FDA in 1987. This drug is available in cream and suppository forms and both have demonstrated high levels of safety, efficacy, and tolerability in clinical trials.Due to the existence of 2 stereocentres, there are 4 possible stereoisomers for terconazole.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- 1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine
- InChIKey
- BLSQLHNBWJLIBQ-OZXSUGGESA-N
- SMILES
- CC(C)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl
- Other CAS numbers recorded
- 172587-59-6
- PubChem CID
- 441383
Also known as
terconazole · Gyno-Terazol · Terazol 3 · Terazol 7 · Triaconazole · Terazol · Fungistat · Panlomyc
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.